Chemistry: A European Journal 2000-12-01

Pseudoprolines (psiPro) in drug design: direct insertion of psiPro systems into cyclosporin C.

M Keller, T Wöhr, P Dumy, L Patiny, M Mutter

Index: Chemistry 6(23) , 4358-63, (2000)

Full Text: HTML

Abstract

The insertion of acetals that exhibit variable structural features into complex peptides such as cyclosporin C (CsC) results in oxazolidine derivatives (pseudoprolines, psiPro) of tailored physico-chemical and biological properties. N,O-Acetalation of the 2-threonine hydroxyl group and the preceding amide nitrogen of CsC is achieved by treating the molecule with a number of both arylated and non-arylated dimethyl acetals. The psiPro-containing CsC derivatives exhibit enhanced conformational backbone rigidity, as suggested by analytical HPLC, NMR spectroscopy and by kinetic measurements on binding with their receptor protein cyclophilin A (CypA) that were not time-dependent. IC50 values for calf-thymus CypA were obtained by kinetic evaluation of its cis-->trans isomerase activity. The choice of the para-substituted aryl dimethyl acetals allows the inhibitory properties of the corresponding derivatives to be modulated to either prodrugs or moderately strongly binding cyclosporin C derivatives.

Related Compounds

  • Thr2-Cyclosporine

Related Articles:

Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.

1992-07-01

[Clin. Exp. Immunol. 89(1) , 136-42, (1992)]

Tachykinin antagonists screening from microbial origin.

1996-01-01

[J. Antibiot. 49(1) , 110-2, (1996)]

Monitoring cyclosporine by HPLC with cyclosporin C as internal standard.

1993-01-01

[Clin. Chem. 39(1) , 168, (1993)]

Use of 125I-labeled-histamine-cyclosporin C for monitoring serum cyclosporine concentrations in transplantation patients.

1986-03-01

[Clin. Chem. 32(3) , 492-5, (1986)]

Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.

2003-07-01

[J. Heart Lung Transplant. 22(7) , 715-22, (2003)]

More Articles...